heparan sulfate
Summary
Heparan sulfate is a sulfated glycosaminoglycan (GAG) found covalently attached to core proteins as heparan sulfate proteoglycans (HSPGs), a major component of the basement membrane (e.g., glomerular basement membrane) and cell surfaces. It contributes to the negative charge that restricts filtration of anionic macromolecules like albumin. It is also structurally related to heparin and plays roles in cell signaling, growth factor binding, and coagulation modulation.
Detail
Heparan sulfate is a linear polysaccharide composed of repeating disaccharide units (glucosamine and uronic acid) that undergo variable sulfation. It exists mainly as heparan sulfate proteoglycans (HSPGs) such as perlecan and agrin, which are key structural components of the basement membrane, particularly the glomerular basement membrane (GBM) in the kidney. The high density of negative charges from sulfate and carboxyl groups creates a charge-selective barrier that normally prevents filtration of negatively charged plasma proteins like albumin.
Clinical relevance: - Nephrotic syndrome: Loss of heparan sulfate from the GBM (as seen in minimal change disease and diabetic nephropathy) reduces the charge barrier, leading to selective proteinuria (albuminuria) despite a normal-appearing GBM on light microscopy. This is a classic USMLE concept linking GAG loss to proteinuria. - Diabetes mellitus: Hyperglycemia leads to nonenzymatic glycation and reduced synthesis of heparan sulfate, contributing to diabetic nephropathy and increased vascular permeability. - Coagulation: Endothelial-associated heparan sulfate has intrinsic anticoagulant properties by binding antithrombin III, similar to heparin, and is relevant in disseminated intravascular coagulation (DIC) and endothelial injury syndromes (e.g., sepsis-induced 'auto-heparinization'). - Growth factor signaling: HSPGs act as co-receptors for FGF and other growth factors, influencing angiogenesis, wound healing, and tumor growth. - Genetic disorders: Mutations affecting heparan sulfate metabolism are implicated in mucopolysaccharidoses (e.g., Hunter and Sanfilippo syndromes) due to deficient degradation enzymes (iduronate sulfatase, heparan sulfatase), leading to GAG accumulation in lysosomes.
Understanding heparan sulfate’s role in the GBM and its loss in nephrotic syndrome is a frequently tested concept on Step 1.
Sources
- First Aid for the USMLE Step 1
- Robbins and Cotran Pathologic Basis of Disease
- Guyton and Hall Textbook of Medical Physiology
- Costanzo Physiology
Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.